Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Extension Study With REQUIP (Ropinirole) CR for Subjects From Studies 101468/165, 101468/168 and 101468/169

NCT00632736 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00632736
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00632736 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Extension Study With REQUIP (Ropinirole) CR for Subjects From Studies 101468/165, 101468/168 and 101468/169
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2004
Completion date
March 31, 2010
Enrollment
419 (actual)
Sites
75

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease, parkinson's disease